Heyholder
‹ Disclosures

KWANGDONG PHARMACEUTICAL CO.,LTD Earnings Release Notice

KWANGDONG PHARMACEUTICAL CO.,LTD
View original on DART ↗0 votes · 0 comments

AI summary · Not investment advice

Kwangdong Pharmaceutical announced it plans to disclose its financial results for the period from January 1, 2026 to September 30, 2026 on November 11, 2026.

Key facts

Reporting period
Jan 1, 2026 – Sep 30, 2026
Earnings disclosure date
Nov 11, 2026The schedule may change depending on the company's circumstances.

Commentary

AI commentary · Not investment advice

What happened

Kwangdong Pharmaceutical filed a advance notice of its earnings announcement on 2026.10.30. The company said it plans to disclose its results for the period from 2026.01.01 to 2026.09.30 on 2026.11.11.

In the company's terms

This filing is a schedule notice and does not contain the results themselves. The materials give no figures such as revenue or operating profit, no ratios, and no comparison with prior periods. The actual numbers will be available in the announcement scheduled for 2026.11.11.

Show Korean comments

Comments

No comments yet

Comments from shareholders will appear here.